NSEAnalysts/Institutional Investor Meet/Con. Call Updates6d ago · 6 Aug 2026, 06:31 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Zota Health Care LImited · ZOTA

✦ AI SummaryResults

Zota Health Care Limited has informed the Exchange about Intimation of Schedule of Earnings Conference Call on Q1FY27 Results.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Zota Health Care Limited has informed the Exchange about Intimation of Schedule of Earnings Conference Call on Q1FY27 Results

Attachments (1)

📄

ZOTA_06082026183113_IntEC06082026.pdf

pdf

Download →
View document text
August 06, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub.: Intimation of Schedule of Earnings Conference Call on Q1FY27 Results Ref.: Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject; we, Zota Health Care Limited (the “Company”), would like to inform you that the Company will host an Earnings Call on Q1FY27 Results on Friday, August 14, 2026 at 11:30 hrs. (IST). The conference call invitation is enclosed herewith. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl.: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 ress Release – Q2FY22 Earnings Call Invite Q1FY27 Zota Health Care Limited Q1FY27 Earnings Call to be held on Friday, August 14, 2026, at 11:30 hrs. (IST) Surat, August 06, 2026: Zota Health Care Limited, one of the leading pharmaceutical Company with an aim to provide affordable, high-quality, generic medicines predominantly for chronic conditions, in addition to proprietary medicinal, OTC, ayurvedic, cosmetic, and nutraceutical products, will announce financial results for the first quarter ended June 30, 2026 on August 13, 2026. Following the announcement, the management of the Company will host an Earnings Call on Friday, August 14, 2026, at 11:30 hrs. (IST). The Details of Q1FY27 Earnings Call are: Date: Friday, August 14, 2026 Time: 11:30 hrs. IST Duration: 60 minutes Dial-in Details: Participants are encouraged to dial in 10 minutes prior to the call start time to avoid last-minute hold times. If you reach an operator during the dial-in process, please inform them that you would like to join the “Zota Health Care Limited Q1FY27 Earnings Conference Call’. Universal Dail in numbers +91 22 6280 1107 / +91 22 7115 8008 Pre-Registration Facility • Step 1: Pre-register here. You will receive an email confirmation with the call details on the registered email address. • Step 2: Dial into the call on the Conference Call date, you will be directly connected to the call. Management Representation from Zota Health Care Limited Mr. Himanshu Zota - Founder and Whole-time Director Mr. Moxesh Zota - Managing Director Dr. Sujit Paul - Group Chief Executive Officer About Zota Health Care Limited: Zota Health Care Ltd. (Zota), listed on the NSE, has been a key player in the Indian healthcare industry since 2000. Headquartered in Surat, Zota's team of over 620 professionals drives its growth and strong market presence. The Company specializes in the development, manufacturing, and marketing of high-quality pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. ZOTA HEALTHCARE LIMITED | WWW.ZOTAHEALTHCARE.COM | Q1FY2027 EARNINGS CALL INVITE | PAGE 1 OF 2 ress Release – Q2FY22 Earnings Call Invite Q1FY27 Zota operates through three main divisions: marketing, export, and the retail pharmacy chain. In 2017, Zota launched Davaindia, a generic pharmacy chain offering over 2,000 SKUs of quality medicines. Davaindia's strategic business model ensures efficient management of the entire product life cycle through backward and forward integration. Zota is renowned for its innovative Research and Development team, consistently investing in pioneering healthcare solutions, reinforcing its reputation in the industry. For more information, visit: www.zotahealthcare.com. For details please contact: Ashvin Variya Siddesh Chawan Ajit Mishra Group Company Secretary & Compliance Officer Ernst & Young LLP, Ernst & Young LLP, Zota Health Care Ltd Investor Relations Investor Relations E: cszota@zotahealthcare.com E: Siddesh.Chawan@in.ey.com E: Ajit.J.Mishra@in.ey.com Disclaimer: Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political, or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. Zota Health Care Ltd. will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances. ZOTA HEALTHCARE LIMITED | WWW.ZOTAHEALTHCARE.COM | Q1FY2027 EARNINGS CALL INVITE | PAGE 2 OF 2